Astrazeneca (AZN) Net Shares Issued and Repurchased (2010 - 2012)

Astrazeneca has reported Net Shares Issued and Repurchased for 3 years, with the latest figure at -$2.6 billion in Q4 2012.

• On a quarterly basis, Net Shares Issued and Repurchased fell 143.81% year-over-year to -$2.6 billion in Q4 2012; TTM through Dec 2012 was -$2.6 billion, a 143.81% decrease from a year earlier, with the FY2012 full-year figure at -$2.6 billion, down 143.81% from the prior year.
• Net Shares Issued and Repurchased was -$2.6 billion for Q4 2012 at Astrazeneca, down from $6.0 billion in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $6.0 billion in Q4 2011, with the low at -$2.6 billion in Q4 2012.
• Average Net Shares Issued and Repurchased over 3 years is -$49.0 million, with a median of -$1.3 billion recorded in 2011.
• The largest YoY upside for Net Shares Issued and Repurchased was 385.07% in 2011 against a maximum downside of 507.94% in 2011.
• Over 3 years, Net Shares Issued and Repurchased stood at -$2.1 billion in 2010, then soared by 385.07% to $6.0 billion in 2011, then plunged by 143.81% to -$2.6 billion in 2012.
• The last three Net Shares Issued and Repurchased figures came in at -$2.6 billion (Q4 2012), $6.0 billion (Q4 2011), and -$1.3 billion (Q1 2011), per Business Quant data.